(Reuters) - CVS Caremark Corp will buy drug infusion services provider Coram LLC for $2.1 billion, allowing the company to bolster its pharmacy benefits management business by offering cost-effective delivery of specialty drugs. Most pharma companies are increasingly focused on developing niche drugs for complex disorders as several mass market drugs lose patent protection. Pharmacy benefit managers (PBMs) such as CVS, which administer prescription drug benefits for employers and health plans, can offer greater value to clients by diversifying their offerings. CVS, which operates the No. 2 ...
via Health News Headlines - Yahoo! News http://news.yahoo.com/cvs-caremark-buy-aprias-infusion-business-2-1-134620173--finance.html
No comments:
Post a Comment